Platelet-vessel Wall Interactions: Implication of 5-hydroxytryptamine. A Review

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1984 Dec 1

PMID 6397984

Citations 8

Authors

F de Clerck

J M VAN NUETEN

R S Reneman

Affiliations

Soon will be listed here.

Abstract

The evidence for an impact of platelet-derived 5-hydroxytryptamine (5-HT) on local tissue perfusion is reviewed. By interacting with 5-HT2 serotonergic receptors, 5-HT, directly or through amplification, activates platelets, endothelial and vascular smooth muscle cells producing platelet aggregation, vascular permeability increase and large vessel constriction. Pharmacodissection in experimental animals with selective serotonergic 5-HT2 receptor antagonists, e.g. ketanserin, shows that 5-HT largely contributes to the platelet-mediated increase in vascular permeability, to platelet-vessel wall interaction during hemostasis, to cardiopulmonary dysfunction provoked by thromboembolism and to the platelet-mediated inhibition of peripheral collateral circulation. Clinical results obtained with ketanserin further substantiate an involvement of platelet-derived 5-HT in the pathogenesis of impaired tissue perfusion in some cardiovascular conditions.

Citing Articles

Validation of canine uterine and testicular arteries for the functional characterisation of receptor-mediated contraction as a replacement for laboratory animal tissues in teaching.

Mulcahy L, Tudor E, Bailey S PLoS One. 2020; 15(5):e0230516.

PMID: 32453770 PMC: 7250439. DOI: 10.1371/journal.pone.0230516.

Platelets and cardiac arrhythmia.

de Jong J, Dekker L Front Physiol. 2011; 1:166.

PMID: 21423401 PMC: 3059929. DOI: 10.3389/fphys.2010.00166.

Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.

Gleerup G, Persson B, Hedner T, Winther K Eur J Clin Pharmacol. 1993; 44(2):121-5.

PMID: 8453957 DOI: 10.1007/BF00315468.

Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.

Prosdocimi M, Zatta A, Finesso M Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(4):430-7.

PMID: 3244385 DOI: 10.1007/BF00172123.

The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.

Stott D, Saniabadi A, Hosie J, Lowe G, Ball S Eur J Clin Pharmacol. 1988; 35(2):123-9.

PMID: 3142775 DOI: 10.1007/BF00609240.

References

VAN NUETEN J, Janssen P, van Beek J, XHONNEUX R, Verbeuren T, Vanhoutte P . Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther. 1981; 218(1):217-30. View

Todd M, Forrest J, Cragg D . The effects of aspirin and methysergide on responses to clot-induced pulmonary embolism. Am Heart J. 1983; 105(5):769-76. DOI: 10.1016/0002-8703(83)90239-9. View

Zahavi J, Kakkar V . beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction. Thromb Haemost. 1980; 44(1):23-9. View

Siegel M, McConnell R, Cuatrecasas P . Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc Natl Acad Sci U S A. 1979; 76(8):3774-8. PMC: 383916. DOI: 10.1073/pnas.76.8.3774. View

Cohen M, Mason N, Wiley K, Fuller R . Further evidence that vascular serotonin receptors are of the 5HT2 type. Biochem Pharmacol. 1983; 32(3):567-70. DOI: 10.1016/0006-2952(83)90541-5. View

Moncada S, Vane J . Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978; 30(3):293-331. View

VAN NUETEN J, Vanhoutte P . Selectivity of calcium antagonism and serotonin antagonism with respect to venous and arterial tissues. Angiology. 1981; 32(7):476-84. DOI: 10.1177/000331978103200704. View

Hope W, Martin T, Chesterman C, Morgan F . Human beta-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells. Nature. 1979; 282(5735):210-2. DOI: 10.1038/282210a0. View

Gabbiani G, Badonnel M, Majno G . Intra-arterial injections of histamine, serotonin, or bradykinin: a topographic study of vascular leakage. Proc Soc Exp Biol Med. 1970; 135(2):447-52. DOI: 10.3181/00379727-135-35072. View

10.

Halpern A, Kuhn P, SHAFTEL H, SAMUELS S, SHAFTEL N, SELMAN D . Raynaud's disease, Raynaud's phenomenon, and serotonin. Angiology. 1960; 11:151-67. DOI: 10.1177/000331976001100301. View

11.

Moncada S, Vane J . Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979; 300(20):1142-7. DOI: 10.1056/NEJM197905173002006. View

12.

Preston F, Ward J, Marcola B, Porter N, Timperley W, OMalley B . Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet. 1978; 1(8058):238-40. DOI: 10.1016/s0140-6736(78)90483-x. View

13.

de Clerck F, Xhonneux B, Leysen J, Janssen P . Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem Pharmacol. 1984; 33(17):2807-11. DOI: 10.1016/0006-2952(84)90699-3. View

14.

Udaka K, Takeuchi Y, Movat H . Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970; 133(4):1384-7. DOI: 10.3181/00379727-133-34695. View

15.

Hornstra G, Haddeman E, Don J . Blood platelets do not provide endoperoxides for vascular prostacyclin production. Nature. 1979; 279(5708):66-8. DOI: 10.1038/279066a0. View

16.

Vanhoutte P, Cohen R . The elusory role of serotonin in vascular function and disease. Biochem Pharmacol. 1983; 32(24):3671-4. DOI: 10.1016/0006-2952(83)90134-x. View

17.

Somlyo A, Somlyo A . Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels. Pharmacol Rev. 1970; 22(2):249-353. View

18.

de Clerck F, David J . Pharmacological control of platelet and red blood cell function in the microcirculation. J Cardiovasc Pharmacol. 1981; 3(6):1388-412. DOI: 10.1097/00005344-198111000-00026. View

19.

Sullivan J . Prostaglandins and regulation of blood pressure: clinical implications. Pharmacol Ther. 1981; 15(3):447-65. DOI: 10.1016/0163-7258(81)90054-1. View

20.

Majno G, Shea S, Leventhal M . Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol. 1969; 42(3):647-72. PMC: 2107712. DOI: 10.1083/jcb.42.3.647. View